Skip to content
September 1, 2014
August 22nd, 2011.
Novo A/S and Novozymes A/S have today agreed the financial terms governing the spin out of the Arenicin-3 family including variant library from Novozymes A/S to Adenium Biotech ApS.
August 17th, 2011.
Novo A/S has today established Adenium Biotech ApS through a Seed Financing.